Onco-surgical management of colo-rectal liver metastases in older patients: A new frontier in the 3rd millennium

Anti-Cancer Agents in Medicinal Chemistry

Volumn 13, Issue 9, 2013, Pages 1354-1363

  Di Benedetto, Fabrizio ^a   D'Amico, Giuseppe ^a   Spaggiari, Mario ^b   Tirelli, Umberto ^c   Berretta, Massimiliano ^c  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Digestive Disease Institute   (United States)

^c CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Colorectal liver metastases; Elderly patients; Morbility and mortality; Onco surgical management

Indexed keywords

BEVACIZUMAB; CARCINOEMBRYONIC ANTIGEN; CETUXIMAB; FLUORODEOXYGLUCOSE F 18; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; PANITUMUMAB;

ADJUVANT CHEMOTHERAPY; AGE; ARTICLE; CANCER PROGNOSIS; COLORECTAL CANCER; COLORECTAL LIVER METASTASIS; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; ECHOCARDIOGRAPHY; GERIATRIC ASSESSMENT; HUMAN; LAPAROSCOPIC SURGERY; LIVER HYPERTROPHY; LIVER RESECTION; MINIMALLY INVASIVE SURGERY; MULTICENTER STUDY (TOPIC); NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITIONAL STATUS; OVERALL SURVIVAL; PEROPERATIVE CHOLANGIOGRAPHY; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SENSITIVITY AND SPECIFICITY; SURGICAL RISK; VEIN EMBOLISM; AGED; COLORECTAL NEOPLASMS; LIVER NEOPLASMS; PATHOLOGY; RISK ASSESSMENT; SECONDARY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; RISK ASSESSMENT;

EID: 84888229241     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/18715206113136660344     Document Type: Article

References (106)

1. Faivre, J., Manfredi, S., Bouvier, A.M. Epidemiology of colorectal cancer liver metastases. Bull. Acad. Natl. Med., 2003, 187(5), 815-822. discussion 822-813.
2. Geoghegan, J.G., Scheele, J. Treatment of colorectal liver metastases. Br. J. Surg., 1999, 86(2), 158-169.
3. Welch, J.P., Donaldson, G.A. The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann. Surg., 1979, 189(4), 496-502.
4. Bouvier, A.M., Remontet, L., Jougla, E., Launoy, G., Grosclaude, P., Buemi, A., et al. Incidence of gastrointestinal cancers in France. Gastroenterol. Clin. Biol., 2004, 28(10 Pt 1), 877-881.
5. Rastogi, T., Hildesheim A, Sinha R. Opportunities for cancer epidemiology in developing countries. Nat. Rev. Cancer, 2004, 4(11), 909-917.
6. Petrowsky, H, Clavien PA. Should we deny surgery for malignant hepato-pancreatico-biliary tumors to elderly patients? World J. Surg., 2005, 29(9), 1093-1100.
7. Zacharias, T, Jaeck D, Oussoultzoglou E, Bachellier P, Weber JC. First and repeat resection of colorectal liver metastases in elderly patients. Ann. Surg., 2004, 240(5), 858-865.
8. Adam, R, Frilling A, Elias D, Laurent C, Ramos E, Capussotti L et al. Liver resection of colorectal metastases in elderly patients. Br. J. Surg., 2010, 97(3), 366-376.
9. Fong, Y., Fortner, J., Sun, R.L., Brennan, M.F., Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer, analysis of 1001 consecutive cases. Ann. Surg., 1999, 230(3), 309-318. discussion 318-321.
10. Temple, L.K., Hsieh, L., Wong, W.D., Saltz L, Schrag D. Use of surgery among elderly patients with stage IV colorectal cancer. J. Clin. Oncol., 2004, 22(17), 3475-3484.
11. de Liguori Carino N, van Leeuwen BL, Ghaneh P, Wu A, Audisio RA, Poston GJ. Liver resection for colorectal liver metastases in older patients. Crit. Rev. Oncol. Hematol., 2008, 67(3), 273-278.
12. Jemal, A., Bray, F., Crnter, M.M., Ferlay, J., Ward, E., Forman, D. Global cancer statistics. CA Cancer J. Clin., 2011, 61(2), 69-90.
13. Brown RE, Bower MR, Martin RC. Hepatic resection for colorectal liver metastases. Surg. Clin. North Am., 2010, 90(4), 839-852.
14. Choti, M.A., Sitzmann, JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann. Surg., 2002, 235(6), 759-766.
15. Rees, M., Tekkis, P.P., Welsh, F.K., O'Rourke, T., John, T.G. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer, a multifactorial model of 929 patients. Ann. Surg., 2008, 247(1), 125-135.
16. Nasti, G., Ottaiano, A., Berretta, M., Delrio, P., Izzo, F., Cassata, A., et al. Pre-operative chemotherapy for colorectal cancer liver metastases, an update of recent clinical trials. Cancer Chemother. Pharmacol., 2010, 66(2), 209-218.
17. Hughes, K.S., Simon, R., Songhorabodi, S., Adson, M.A., Ilstrup, D.M., Fortner, J.G., et al. Resection of the liver for colorectal carcinoma metastases, a multi-institutional study of patterns of recurrence. Surgery, 1986, 100(2), 278-284.
18. Sharma, S., Camci, C., Jabbour, N. Management of hepatic metastasis from colorectal cancers, an update. J. Hepatobiliary Pancreat. Surg., 2008, 15(6), 570-580.
19. Abdalla, E.K., Vauthey, J.N., Ellis, L.M., Ellis, V., Pollock, R., Broglio, K.R., et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann. Surg., 2004, 239(6), 818-825. discussion 825-817.
20. Bentrem, D.J., Dematteo, R.P., Blumgart, L.H. Surgical therapy for metastatic disease to the liver. Annu. Rev. Med., 2005, 56, 139-156.
21. Gayowski, T.J., Iwatsuki, S., Madariaga, J.R., Selby, R., Todo, S., Irish, W., et al. Experience in hepatic resection for metastatic colorectal cancer, analysis of clinical and pathologic risk factors. Surgery, 1994, 116(4), 703-710. discussion 710-701.
22. Nordlinger, B., Guiguet, M., Vaillant, J.C., Balladur, P., Boudjema, K., Bachellier, P., et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer, 1996, 77(7), 1254-1262.
23. Mann, C.D., Neal, C.P., Pattenden, C.J., Metcalfe, M.S., Garcea, G., Dennison, A.R., et al. Major resection of hepatic colorectal liver metastases in elderly patients-an aggressive approach is justified. Eur. J. Surg. Oncol., 2008, 34(4), 428-432.
24. Cannon, R.M., Martin, R.C., Callender, G.G., McMasters, K.M., Scoggins, C.R. Safety and efficacy of hepatectomy for colorectal metastases in the elderly. J. Surg. Oncol., 2011, 104(7), 804-808.
25. Kulik, U., Framke, T., Grosshennig, A., Ceylan, A., Bektas, H., Klempnauer, J., et al. Liver resection of colorectal liver metastases in elderly patients. World J. Surg., 2011, 35(9), 2063-2072.
26. Bipat S, van Leeuwen MS, Comans EF, Pijl ME, Bossuyt PM, Zwinderman AH et al. Colorectal liver metastases, CT, MR imaging, and PET for diagnosis--meta-analysis. Radiology, 2005, 237(1), 123-131.
27. Kinkel, K., Lu, Y., Both, M., Warren, R.S., Thoeni, RF. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET), a meta-analysis. Radiology, 2002, 224(3), 748-756.
28. Steele, G. Jr., Bleday R., Mayer, R.J., Lindblad, A., Petrelli, N., Weaver, D. A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver, Gastrointestinal Tumor Study Group Protocol 6584. J. Clin. Oncol., 1991, 9(7), 1105-1112.
29. Kamel, I.R., Choti, M.A., Horton, K.M., Braga, H.J., Birnbaum, B.A., Fishman, E.K., et al. Surgically staged focal liver lesions, accuracy and reproducibility of dual-phase helical CT for detection and characterization. Radiology, 2003, 227(3), 752-757.
30. Solomon, R. Contrast-induced acute kidney injury (CIAKI). Radiol. Clin. North Am., 2009 Sep, 47(5), 783-8.
31. del Frate, C., Bazzocchi, M., Mortele, K.J., Zuiani, C., Londero, V., Como, G., et al. Detection of liver metastases, comparison of gadobenate dimeglumine-enhanced and ferumoxides-enhanced MR imaging examinations. Radiology, 2002, 225(3), 766-772.
32. Kim, M.J., Kim, J.H., Chung, J.J., Park, M.S., Lim, J.S., Oh, Y.T. Focal hepatic lesions, detection and characterization with combination gadolinium-and superparamagnetic iron oxideenhanced MR imaging. Radiology, 2003, 228(3), 719-726.
33. Ward, J., Guthrie, J.A., Wilson, D., Arnold, P., Lodge, J.P., Toogood, G.J., et al. Colorectal hepatic metastases, detection with SPIO-enhanced breath-hold MR imaging--comparison of optimized sequences. Radiology, 2003, 228(3), 709-718.
34. Muhi, A., Ichikawa, T., Motosugi, U., Sou, H., Nakajima, H., Sano, K., et al. Diagnosis of colorectal hepatic metastases, Contrastenhanced ultrasonography versus contrast-enhanced computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging with diffusion-weighted imaging. J. Magn. Reson. Imaging, 2010, 32(5), 1132-1140.
35. Wiering, B., Krabbe, P.F., Jager, G.J., Oyen, W.J., Ruers, T.J. The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases. Cancer, 2005, 104(12), 2658-2670.
36. Zhuang, H., Sinha, P., Pourdehnad, M., Duarte, P.S., Yamamoto, A.J., Alavi, A. The role of positron emission tomography with fluorine-18-deoxyglucose in identifying colorectal cancer metastases to liver. Nucl. Med. Commun., 2000, 21(9), 793-798.
37. Selzner, M., Hany, T.F., Wildbrett, P., McCormack, L., Kadry, Z., Clavien, P.A. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann. Surg., 2004, 240(6), 1027-1034. discussion 1035-1026.
38. Lubezky, N., Metser, U., Geva, R., Nakache, R., Shmueli, E., Klausner, J.M., et al. The role and limitations of 18-fluoro-2deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy, comparison with operative and pathological findings. J. Gastrointest. Surg., 2007, 11(4), 472-478.
39. Truant, S., Huglo, D., Hebbar, M., Ernst, O., Steinling, M., Pruvot, F.R. Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases. Br. J. Surg., 2005, 92(3), 362-369.
40. Fleisher, L.A., Beckman, J.A., Brown, K.A., Calkins, H., Chaikof, E., Fleischmann, K.E., et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery, Executive Summary, A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery), Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation, 2007, 116(17), 1971-1996.
41. Caccialanza, R., Palladini, G., Klersy, C., Cereda, E., Bonardi, C., Quarleri, L., Vadacca, G., Albertini, R., Merlini, G. Serum prealbumin, an independent marker of short-term energy intake in the presence of multiple-organ disease involvement. Nutrition, 2013 Mar, 29(3), 580-582
42. Ershler, W.B., Longo, D.L. Aging and cancer, issues of basic and clinical science. J. Natl. Cancer Inst., 1997, 89(20), 1489-1497.
43. Monfardini, S., Yancik, R. Cancer in the elderly, meeting the challenge of an aging population. J. Natl. Cancer Inst., 1993, 85(7), 532-538.
44. Balducci, L., Extermann, M. Cancer and aging. An evolving panorama. Hematol. Oncol. Clin. North Am., 2000, 14(1), 1-16.
45. Balducci, L., Beghe, C. The application of the principles of geriatrics to the management of the older person with cancer. Crit. Rev. Oncol. Hematol., 2000, 35(3), 147-154.
46. Berretta, M., Bearz, A., Frustaci, S., Talamini, R., Lombardi, D., Fratino, L., et al. FOLFOX2 in the treatment of advanced colorectal cancer: a comparison between elderly and middle aged patients. J. Chemother., 2008, 20(4), 503-508.
47. Berretta, M., Cappellani, A., Fiorica, F., Nasti, G., Frustaci, S., Fisichella, R., et al. FOLFOX4 in the treatment of metastatic colorectal cancer in elderly patients, a prospective study. Arch. Gerontol. Geriatr., 2011, 52(1), 89-93.
48. Berretta, M., Zanet, E., Nasti, G., Lleshi, A., Frustaci, S., Fiorica, F., et al. Oxaliplatin-based chemotherapy in the treatment of elderly patients with metastatic colorectal cancer (CRC). Arch. Gerontol. Geriatr., 2012, 55(2), 271-5
49. Bismuth, H., Adam, R., Levi, F., Farabos, C., Waechter, F., Castaing, D, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann. Surg., 1996, 224(4), 509-520. discussion 520-502.
50. Scheele, J., Stang, R., Altendorf-Hofmann, A., Paul, M. Resection of colorectal liver metastases. World J. Surg., 1995, 19(1), 59-71.
51. Adson, M.A. Resection of liver metastases--when is it worthwhile? World J. Surg., 1987, 11(4), 511-520.
52. Fong, Y., Cohen, A.M., Fortner, J.G., Enker, W.E., Turnbull, A.D., Coit, D.G., et al. Liver resection for colorectal metastases. J. Clin. Oncol., 1997, 15(3), 938-946.
53. Kato, T., Yasui, K., Hirai, T., Kanemitsu, Y., Mori, T., Sugihara, K., et al. Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy, analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis. Colon Rectum, 2003, 46(10 Suppl), S22-31.
54. Nordlinger, B., Sorbye, H., Glimelius, B., Poston, G.J., Schlag, P.M., Rougier, P., et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983), A randomised controlled trial. Lancet, 2008, 371(9617), 1007-1016.
55. Goldberg, R.M., Sargent, D.J., Morton, R.F., Fuchs, C.S., Ramanathan, R.K., Williamson, S.K., et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J. Clin. Oncol., 2004, 22(1), 23-30.
56. Tournigand, C., Andre, T., Achille, E., Lledo, G., Flesh, M., Mery-Mignard, D., et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer, A randomized GERCOR study. J. Clin. Oncol., 2004, 22(2), 229-237.
57. Nasti, G., Ottaiano, A., Berretta, M., Delrio, P., Izzo, F., Cassata, A., Romano, C., Facchini, G., Scala, D., Mastro, A., Romano, G., Perri, F., Iaffaioli, R.V. Pre-operative chemotherapy for colorectal cancer liver metastases, an update of recent clinical trials. Cancer Chemother. Pharmacol., 2010 Jul, 66(2), 209-218.
58. Pozzo, C., Basso, M., Cassano, A., Quirino, M., Schinzari, G., Trigila, N., et al. Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann. Oncol., 2004, 15(6), 933-939.
59. Adam, R., Wicherts, D.A., de Haas, R.J., Ciacio, O., Levi, F., Paule, B., et al. Patients with initially unresectable colorectal liver metastases, is there a possibility of cure? J. Clin. Oncol., 2009, 27(11), 1829-1835.
60. Ychou, M., Viret, F., Kramar, A., Desseigne, F., Mitry, E., Guimbaud, R., Delpero, J.R., Rivoire, M., Quénet, F., Portier, G., Nordlinger, B. Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases. Cancer Chemother. Pharmacol., 2008 Jul, 62(2), 195-20
61. Benoist, S., Brouquet, A., Penna, C., Julie, C., El Hajjam, M., Chagnon, S., et al. Complete response of colorectal liver metastases after chemotherapy, does it mean cure? J. Clin. Oncol., 2006, 24(24), 3939-3945.
62. Bokemeyer, C., Bondarenko, I., Makhson, A., Hartmann, J.T., Aparicio, J., de Braud, F., Donea, S., Ludwig, H., Schuch, G., Stroh, C., Loos, A.H., Zubel, A., Koralewski, P. Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the firstline treatment of metastatic colorectal cancer. J. Clin. Oncol., 2009, 27(5), 663-671.
63. National Institute for Health and Clinical Excellence (NICE). Colorectal cancer (first line)-cetuximab, appraisal consultation document. Available at, http://www.nice.org.uk/guidance/index.jsp?action=article&o=42937.
64. Folprecht, G., Gruenberger, T., Bechstein, W.O., Raab, H.R., Lordick, F., Hartmann, J.T., et al. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab, the CELIM randomised phase 2 trial. Lancet Oncol., 2010, 11(1), 38-47.
65. Folprecht, G., Lutz, M.P., Schöffski, P., Seufferlein, T., Nolting, A., Pollert, P., Köhne, C.H. Cetuximab and irinotecan/5-fluorouracil/ folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma. Ann Oncol., 2006, 17(3), 450-456.
66. Raoul, J.L., Van Laethem, J.L., Peeters, M., Brezault, C., Husseini, F., Cals, L., Nippgen, J., Loos, A.H., Rougier, P. Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer, a multicentre two-part phase I/II study. BMC Cancer, 2009, 14(9), 112.
67. Adam, R., Aloia, T., Lévi, F., Wicherts, D.A., de Haas, R.J., Paule, B., et al. Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy. J. Clin. Oncol., 2007, 25(29), 4593-602.
68. Malka, D., Paris, E., Caramella, C., et al. Hepatic arterial infusion (HAI) of oxaliplatin plus intravenous (iv) fluorouracil (FU), leucovorin (LV), and cetuximab for first-line treatment of unresectable colorectal liver metastases (CRLM) (CHOICE), a multicenter phase II study. J. Clin. Oncol., 2010, 28(Suppl.), 7s, (abstract 3558).]
69. Hofheinz, R., Mineur, L., Griel, R, et al. Panitumumab (pmab) with FOLFIRI as first-line treatment of patients (pts) with metastatic colorectal cancer (mCRC), resections and curative surgery in a phase II single arm, multicenter study (20060314). J. Clin. Oncol., 2010, 28(Suppl.), 7s, (abstract 3545).].
70. Levey, A.S., Coresh, J., Greene, T., Stevens, L.A., Zhang, Y.L., Hendriksen, S., Kusek, J.W., Van Lente, F. Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann. Intern. Med., 2006, 145(4), 247-54.
71. Hughes, K.S., Rosenstein, R.B., Songhorabodi, S., Adson, M.A., Ilstrup, D.M., Fortner, J.G., et al. Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis. Colon Rectum, 1988, 31(1), 1-4.
72. Minagawa, M., Makuuchi, M., Torzilli, G., Takayama, T., Kawasaki, S., Kosuge, T., et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer, long-term results. Ann. Surg., 2000, 231(4), 487-499.
73. Adam, R., Delvart, V., Pascal, G., Valeanu, A., Castaing, D., Azoulay, D., et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy, a model to predict long-term survival. Ann. Surg., 2004, 240(4), 644-657. discussion 657-648.
74. Vauthey, J.N., Zorzi, D., Pawlik, T.M. Making unresectable hepatic colorectal metastases resectable--does it work? Semin. Oncol., 2005, 32(6 Suppl 9), S118-122.
75. Altendorf-Hofmann, A., Scheele, J. A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma. Surg. Oncol. Clin. N Am., 2003, 12(1), 165-192.
76. Elias, D., Ouellet, J.F., Bellon, N., Pignon, J.P., Pocard, M., Lasser, P. Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br. J. Surg., 2003, 90(5), 567-574.
77. Inoue, M., Ohta, M., Iuchi, K., Matsumura, A., Ideguchi, K., Yasumitsu, T., et al. Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma. Ann. Thorac. Surg., 2004, 78(1), 238-244.
78. Kokudo, N., Imamura, H., Sugawara, Y., Sakamoto, Y., Yamamoto, J., Seki, M., et al. Surgery for multiple hepatic colorectal metastases. J. Hepatobiliary Pancreat. Surg., 2004, 11(2), 84-91.
79. Abdalla, E.K., Barnett, C.C., Doherty, D., Curley, S.A., Vauthey, J.N. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch. Surg., 2002, 137(6), 675-680. discussion 680-671.
80. Vauthey, J.N., Pawlik, T.M., Abdalla, E.K., Arens, J.F., Nemr, R.A., Wei, S.H., et al. Is extended hepatectomy for hepatobiliary malignancy justified? Ann. Surg., 2004, 239(5), 722-730. discussion 730-722.
81. Shoup, M., Gonen, M., D'Angelica, M., Jarnagin, W.R., De Matteo, R.P., Schwartz, L.H., et al. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J. Gastrointest. Surg., 2003, 7(3), 325-330.
82. Akita, H., Sasaki, Y., Yamada, T., Gotoh, K., Ohigashi, H., Eguchi, H., et al. Real-time intraoperative assessment of residual liver functional reserve using pulse dye densitometry. World J. Surg., 2008, 32(12), 2668-2674.
83. Sakka, S.G. Assessing liver function. Curr. Opin. Crit. Care, 2007 Apr, 13(2), 207-214.
84. Wynne, H.A., Cope, L.H., Mutch, E., Rawlins, M.D., Woodhouse, K.W., James, O.F. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology, 1989, 9(2), 297-301.
85. James, O.F. Gastrointestinal and liver function of old age. Clin. Gastroenterol., 1983, 12(3), 671-691.
86. Abdalla, E.K., Hicks, M.E., Vauthey, J.N. Portal vein embolization, rationale, technique and future prospects. Br. J. Surg., 2001, 88(2), 165-175.
87. Tanaka, K., Shimada, H., Matsuo, K., Ueda, M., Endo, I., Togo, S. Remnant liver regeneration after two-stage hepatectomy for multiple bilobar colorectal metastases. Eur. J. Surg. Oncol., 2007, 33(3), 329-335.
88. Vauthey, J.N., Pawlik, T.M., Ribero, D., Wu, T.T., Zorzi, D., Hoff, P.M., et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J. Clin. Oncol., 2006, 24(13), 2065-2072.
89. Makuuchi, M., Thai, B.L., Takayasu, K., Takayama, T., Kosuge, T., Gunven, P., et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma, a preliminary report. Surgery, 1990, 107(5), 521-527.
90. Hemming, A.W., Reed, A.I., Howard, R.J., Fujita, S., Hochwald, S.N., Caridi, J.G., et al. Preoperative portal vein embolization for extended hepatectomy. Ann. Surg., 2003, 237(5), 686-691. discussion 691-683.
91. Pamecha, V., Nedjat-Shokouhi, B., Gurusamy, K., Glantzounis, G.K., Sharma, D., Davidson, B.R. Prospective evaluation of two-stage hepatectomy combined with selective portal vein embolisation and systemic chemotherapy for patients with unresectable bilobar colorectal liver metastases. Dig. Surg., 2008, 25(5), 387-393.
92. Goéré, D., Farges, O., Leporrier, J., Sauvanet, A., Vilgrain, V., Belghiti, J. Chemotherapy does not impair hypertrophy of the left liver after right portal vein obstruction. J. Gastrointest. Surg., 2006, 10(3), 365-370.
93. Chun, Y.S., Vauthey, J.N., Ribero, D., Donadon, M., Mullen, J.T., Eng, C., et al. Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases, perioperative safety and survival. J. Gastrointest. Surg., 2007, 11(11), 1498-1504.
94. Beal, I.K., Anthony, S., Papadopoulou, A., Hutchins, R., Fusai, G., Begent, R., Davies, N., Tibballs, J., Davidson, B. Portal vein embolisation prior to hepatic resection for colorectal liver metastases and the effects of periprocedure chemotherapy. Br. J. Radiol., 2006, 79(942), 473-478.
95. Oussoultzoglou, E., Bachellier, P., Rosso, E., Scurtu, R., Lucescu, I., Greget, M., et al. Right portal vein embolization before right hepatectomy for unilobar colorectal liver metastases reduces the intrahepatic recurrence rate. Ann. Surg., 2006, 244(1), 71-79.
96. Sakon, M., Nagano, H., Nakamori, S., Dono, K., Umeshita, K., Murakami, T., et al. Intrahepatic recurrences of hepatocellular carcinoma after hepatectomy, analysis based on tumor hemodynamics. Arch. Surg., 2002, 137(1), 94-99.
97. Belghiti, J., Clavien, P.A., Gadzijev, E., Garden, J.O., Lau, W.Y., Makuuchi, M., Strong RW. The Brisbane 2000 Terminology of Liver Anatomy and Resections. HBP, 2000, 2(3), 333-339
98. Uchiyama, K., Ueno, M., Ozawa, S., Kiriyama, S., Shigekawa, Y., Yamaue, H. Combined use of contrast-enhanced intraoperative ultrasonography and a fluorescence navigation system for identifying hepatic metastases. World J. Surg., 2010, 34(12), 2953-2959.
99. Poon, R.T. Current techniques of liver transection. HPB (Oxford), 2007, 9(3), 166-173.
100. Di Benedetto, F., Tarantino, G., Montalti, R., Ballarin, R., D'Amico, G., Di Sandro, S., Gerunda, G.E. Laparoscopic radiofrequency ablation in the caudate lobe for hepatocellular carcinoma before liver transplantation. J. Laparoendosc Adv. Surg. Tech. A., 2012, 22(4), 400-402.
101. Nguyen, K.T., Laurent, A., Dagher, I., Geller, D.A., Steel, J., Thomas, M.T. et al. Minimally invasive liver resection for metastatic colorectal cancer, a multi-institutional, international report of safety, feasibility, and early outcomes. Ann. Surg., 2009, 250(5), 842-848.
102. Abu Hilal, M., Underwood, T., Zuccaro, M., Primrose, J., Pearce, N. Short-and medium-term results of totally laparoscopic resection for colorectal liver metastases. Br. J. Surg., 2010, 97(6), 927-933.
103. Spampinato, M.G., Arvanitakis, M., Puleo, F., Mandala, L., Quarta, G., Traisci, D., Plaia, A., Bartolomeo, N.D., Baldazzi, G., Cillo, U. Totally laparoscopic liver resections for primary and metastatic cancer in the elderly, safety, feasibility and short-term outcomes. Surg. Endosc., 2012 Dec 18.
104. Nagano, Y., Nojiri, K., Matsuo, K., Tanaka, K., Togo, S., Ike, H., et al. The impact of advanced age on hepatic resection of colorectal liver metastases. J. Am. Coll. Surg., 2005, 201(4), 511-516.
105. Bockhorn M, Sotiropoulos GC, Sgourakis G, Neuhaus JP, Molmenti EP, Lang H et al. Major liver resections in the elderly-is an aggressive approach justified? Int. J. Colorectal Dis., 2009, 24(1), 83-86.
106. Cho S.W., Steel J., Tsung, A., Marsh, J.W., Geller, D.A., Gamblin, T.C. Safety of liver resection in the elderly, how important is age? Ann. Surg. Oncol., 2011, 18(4), 1088-1095.